-+ 0.00%
-+ 0.00%
-+ 0.00%

ASIERIS PHARMACEUTICALS ENTERS AN EXCLUSIVE LICENSING AGREEMENT WITH THERAMEX FOR CEVIRA® SUBJECT TO CERTAIN CONDITIONS, ADVANCING THE GLOBAL DEVELOPMENT AND COMMERCIALIZATION OF A NON-SURGICAL TREATMENT FOR CERVICAL PRECANCEROUS LESIONS IN EUROPE

Reuters·10/07/2026 13:37:08